
Ordering Information
| Product Name | Catalog # | UNIT | Price | Qty | FAVORITES | |
hippocalcin CRISPR/Cas9 KO Plasmid (m) | sc-420938 | 20 µg | $397.00 |
Hpca encodes hippocalcin, a neuronal EF-hand calcium-binding protein of the neuronal calcium sensor family that couples Ca2+ transients to changes in synaptic signaling and excitability. Upon Ca2+ binding, hippocalcin undergoes a conformational switch that can modulate membrane association and influence processes such as synaptic plasticity, activity-dependent trafficking, and gene expression programs in neurons. It participates in calcium-dependent signaling networks that intersect with neurotransmitter receptor pathways and downstream kinase/phosphatase cascades shaping long-term potentiation and depression. Dysregulated neuronal Ca2+ homeostasis and altered calcium sensor function are relevant to mechanistic studies of cognitive phenotypes and neurodegenerative or neuropsychiatric disease-associated circuit dysfunction in mouse models.
hippocalcin CRISPR/Cas9 KO Plasmid (m) is a pool of plasmids designed for targeted disruption of the Hpca gene in mouse cell lines. Each plasmid co-expresses a unique single guide RNA (sgRNA) targeting a distinct site within the Hpca together with the Streptococcus pyogenes Cas9 nuclease. The plasmids also encode GFP, allowing fluorescent identification and enrichment of successfully transfected cells by fluorescence microscopy or flow cytometry.
The multi-guide design increases the likelihood of generating insertions or deletions (indels) that disrupt the Hpca open reading frame following Cas9-mediated double-strand break formation. DNA breaks introduced by the CRISPR/Cas9 system are repaired through endogenous non-homologous end joining (NHEJ) pathways, frequently resulting in frameshift mutations that abolish hippocalcin protein expression.
This CRISPR knockout system enables efficient generation of Hpca-deficient cell models for investigation of hippocalcin signaling, functional genomics studies, cancer biology research, and evaluation of therapeutic responses in human cell lines.
CRISPRs +/- HDRs
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.